» Articles » PMID: 25227823

Association Between a Polymorphism in MiR-34b/c and Susceptibility to Cancer--a Meta-analysis

Overview
Specialty Oncology
Date 2014 Sep 18
PMID 25227823
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) act as tumor suppressors or promoters in neoplasia by regulating relative gene expression. The association between a single nucleotide polymorphism (SNP) rs4938723 in miR-34b/c and susceptibility to cancers was inconsistent in previous studies. In this study, we conducted a literature search of PubMed, Web of Science and Embase to identify all relevant studies in this meta-analysis with 6,036 cases and 6,204 controls. We found that the miR-34b/c rs4938723 polymorphism was significantly associated with increased risk of cancers in the heterozygous model (TC versus TT, OR=1.09, 95% CI=1.01-1.18, P=0.02). Subgroup analysis also revealed increased risk for Asian ethnicity in the heterozygous model (TC versus TT, OR=1.12, 95% CI=1.02-1.22, P=0.02), but decreased risk of colorectal cancer in homozygote model (CC versus TT, OR=0.66, 95% CI=0.47-0.92, P=0.02) and in the recessive model (CC versus TC+TT, OR=0.67, 95% CI=0.48-0.93, P=0.02) by cancer type. The current meta-analysis indicated that the miR-34b/c rs4938723 polymorphism may decrease susceptibility to colorectal cancer. Well-designed studies with larger sample size are required to further validate the results.

Citing Articles

Single Nucleotide Polymorphisms in microRNA Genes and Colorectal Cancer Risk and Prognosis.

Radanova M, Levkova M, Mihaylova G, Manev R, Maneva M, Hadgiev R Biomedicines. 2022; 10(1).

PMID: 35052835 PMC: 8773793. DOI: 10.3390/biomedicines10010156.


Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.

Bulibu J, Wang W, Tang Y, Li N, Saifuding K Pathol Oncol Res. 2017; 25(1):421-427.

PMID: 29270777 DOI: 10.1007/s12253-017-0366-4.


An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.

Li H, Diao S, Li J, Ma B, Yuan S Oncotarget. 2017; 8(17):28888-28896.

PMID: 28415817 PMC: 5438700. DOI: 10.18632/oncotarget.16322.


Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.

Sanaei S, Hashemi M, Rezaei M, Hashemi S, Bahari G, Ghavami S Biomed Rep. 2016; 5(1):125-129.

PMID: 27347415 PMC: 4906800. DOI: 10.3892/br.2016.690.


Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy.

Wei B, Huang Q, Zhong X Onco Targets Ther. 2015; 8:1805-14.

PMID: 26229488 PMC: 4516200. DOI: 10.2147/OTT.S78461.